CyTOF ? technology is scaling to new heights, and we’re excited to share what’s coming next in mass cytometry. Adopted in hundreds of clinical trials worldwide, mass cytometry has become an essential tool for immune monitoring and biomarker discovery studies. With the power to analyze 50-plus markers at once, CyTOF systems deliver the sensitivity, resolution, and dynamic range needed to uncover critical immune signatures and cellular mechanisms of disease pathogenesis. In a Phase 2 pancreatic cancer trial at John Hopkins University, mass cytometry revealed treatment-associated immune biomarkers by capturing changes in peripheral immune cell populations which correlated with durable clinical response. https://lnkd.in/egRxCdKQ ?? Stay tuned — exciting updates are just around the corner making it easier for researchers to leverage mass cytometry to identify novel disease drivers and design better therapies. #MassCytometry #Cytometry #ClinicalTrials #Biomarkers #Immune #Disease
Standard BioTools
生物技术研究
South San Francisco,California 33,507 位关注者
Providing essential, standardized tools to accelerate breakthroughs in human health Microfluidics | Cytometry | Imaging
关于我们
Standard BioTools delivers the leading proteomic and multi-omic solutions that enable researchers to discover unique biological insights not accessible by other technologies.
- 网站
-
https://www.standardbio.com
Standard BioTools的外部链接
- 所属行业
- 生物技术研究
- 规模
- 501-1,000 人
- 总部
- South San Francisco,California
- 类型
- 上市公司
- 领域
- Mass Cytometry、Tissue Imaging、NGS Library Prep、Genotyping、Gene Expression、Copy Number Variation、Real-Time PCR和Single-Cell Genomics
地点
Standard BioTools员工
动态
-
Current screening methods can be inaccurate & invasive. Emerging research shows cancer-specific antibodies (IgM & IgG) could revolutionize early detection and monitoring for major cancers like melanoma, breast, prostate, and more! Join our webinar and hear from Jessica Duarte, PhD to learn: ? How antibodies can serve as reliable cancer biomarkers ? Why immune-based blood tests beat traditional methods ? Cutting-edge research on antibody reactivity & prognosis ?? Don’t miss out—register now for expert insights! https://lnkd.in/eptP9riD
-
-
The Proteomics Days Roadshow is back—bigger and better than ever.?? Standard BioTools is hitting the road with an expanded portfolio of powerful multi-omic solutions! Researchers and Standard BioTools? experts will showcase how high-content solutions in serum, spatial and single-cell proteomics are driving groundbreaking research and transformative discoveries. Engage with leading researchers and discover the future of proteomics! ?? Find a stop near you and register today! https://lnkd.in/e-zZmW_G #Spatial #Proteomics #Cell #Research
-
-
We’re expanding our high-plex proteomic offerings with KREX? technology for precision antibody profiling – delivering even more powerful solutions for biopharma and translational research. KREX technology enables autoantibody biomarker detection, deepening disease understanding and accelerating biomarker discovery across autoimmunity, cancer, neurology and beyond. This addition reinforces our commitment to advancing proteomics from basic research to clinical applications. Discover how KREX technology can transform your research: https://lnkd.in/gEy-7DTC #Proteomics #SomaScan #KREX #AntibodyProfiling #BiomarkerDiscovery #TranslationalResearch
-
-
Are you headed to CYTO 2025 this year? Don’t miss your chance to attend the 2025 CyTOF? Summit, a complimentary in-person event just before the start of CYTO! ?? This year, you can win a $500 travel grant for any scientific conference of your choice. How can you enter? Refer a friend or colleague to the 2025 CyTOF Summit and have them mention your name when they register. After the event, both of your names will be entered into a draw. ? Multiple referrals = more chances to win! Register now and learn more about our refer-a-friend travel grant: https://lnkd.in/g-9ju335
-
-
A new independent study from Alkahest – the largest of its kind – compared 7 proteomics platforms, including Olink and mass spectrometry. The results? ?? Click here to learn more and read our latest blog: https://lnkd.in/gU_yAJRd
-
Struggling to identify immune cell types quickly and accurately in your samples?? Join us on Wednesday, March 19 for an insightful webinar, From Blood to Breakthroughs with the Maxpar? Direct Immune Profiling Assay. Learn how this validated, dry-format solution can help you identify major immune cell types with speed and accuracy—all while minimizing variability.? Hear from these amazing speakers as they share their expertise and real-world experiences: ?? Melissa Klug, Standard BioTools ?? Pia Fehrenbach, AO Research Institute Davos & Amsterdam University Medical Center, Amsterdam ??Dr. Sarah Schmidiger, Swiss Tropical and Public Health Institute, Allschwil; University of Basel, Switzerland Register here: https://lnkd.in/e8aGyPqT Discover how the Maxpar? Direct Immune Profiling Assay enables fast, reproducible immune profiling across diverse applications. Don't miss out—register today! #Immune #Profiling #Assay #Reproducible #Cell
-
-
?? Join us at the CyTOF? Summit 2025 on May 30 to hear from Alex Xu, PhD, Assistant Professor at the Fischell Department of Bioengineering, University of Maryland College Park. Xu is an accomplished researcher specializing in #spatial #biology methods applied across different cancer systems. His work explores how cells organize and interact within tissue to uncover predictive #biomarkers and develop new therapy hypotheses. Using highly multiplexed Imaging Mass Cytometry? (IMC?) technology and a novel spatial analytics pipeline, Xu is accelerating the identification of translational biomarkers to clinical outcomes. At this year’s CyTOF Summit, Xu will discuss: ?? Extending spatial biomarkers derived from IMC technology to clinical applications ??Leveraging machine learning tools to predict therapy candidates from spatial data ?? Don’t miss the opportunity to hear from Xu and so many more amazing speakers! Register now: https://lnkd.in/g-9ju335
-
-
We’re thrilled to announce the 2024 SomaScan? Australia Research Grant Award Winners! These outstanding researchers have demonstrated exceptional innovation in advancing biomarker discovery and proteomics research. Jennifer Snaith #Grant #SomaScan #Biomarker #Proteomics
-
-
Are you interested in harnessing the power of high-plex proteomics to advance biomarker discovery and gain deeper insights into disease mechanisms? Join us for the 2025 High-Plex Protein Discovery Day in Basel on Wednesday, March 26 (1:30–5:00 pm) at Universit?tsspital Basel! Discover advancements in high-plex proteomics through insightful presentations from experts from the University of Basel, Novartis and Navignostics AG. Highlights include insights into:?? ?? High-dimensional flow cytometry for single-cell analysis?? ??Imaging Mass Cytometry? (IMC)? technology for mapping tissue architecture and interactions?? ??High-throughput proteomics for biomarker discovery Learn more and register today! https://lnkd.in/eT_b-ybv #Proteomics #Biotech #Protein?#Biomarker #Discovery